Evidence map›Paper›PMID 39773042›Full record

ReviewCurrent medicinal chemistry2026

Enhance Anti-obesity Effect of Natural Compounds through Carrier Mediation.

Mingyue Peng, Hao Wang, Zhenjing Liu, Shaoqian Wang, Haoqiang Qin, Ziyang Wang, Mingxiao Cui, Kehai Liu, Pingping Liu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingyue PengDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Hao WangDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Zhenjing LiuDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Shaoqian WangDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Haoqiang QinDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Ziyang WangDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Mingxiao CuiDepartment of Food Quality and Safety, Shanghai Business School, Shanghai, 201400, China.
Kehai LiuDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.
Pingping LiuDepartment of Biopharmaceutical Science, Shanghai Ocean University, Hucheng Ring Road, Shanghai, 201306, China.

Funding

CSPFTZ Lingang Special Area Marine Biomedical Innovation Platform HZXY-2024-05National Natural Science Foundation, China 82373277
6 · The paper itself

Abstract

Obesity is a global public health problem that can lead to many health complications or comorbidities. Medication alone or in combination with lifestyle changes or surgery is the main way to combat obesity and its complications. Most anti-obesity drugs are limited by their bioavailability, target-specific, and potentially toxic effects, so there is an urgent need for alternative treatments. Based on the new revelation of the pathogenesis of obesity, as well as the efforts of multidisciplinary integration of materials, some emerging obesity treatment strategies are gradually entering the field of preclinical and clinical research. By analyzing the current status and challenges of natural compounds in obesity treatment, this review systematically summarizes the advanced functions and prospects of carrier delivery of natural ingredients in targeted delivery of obesity, as well as their application in obesity treatment. Finally, on the basis of systematic analysis of anti-obesity, the future prospects and challenges in this field are put forward.

Indexed as

Anti-Obesity AgentsBiological ProductsDrug CarriersObesityAnimalsHumansAnti-Obesity AgentsBiological ProductsDrug Carriersanti-obesitycardiovascular diseasecarrier deliveryfat thermogenesis.intestinal floraNatural compounds

Identifiers

PMID39773042

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.